N-acetylcysteine + Placebo

Phase 2Completed

1 views this week 0 watching💤 Quiet

Interest: 35/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Common Cold Associated With Cough

Conditions

Common Cold Associated With Cough

Trial Timeline

Jan 1, 2015 → Apr 1, 2015

NCT ID

NCT02379637

About N-acetylcysteine + Placebo

N-acetylcysteine + Placebo is a phase 2 stage product being developed by Novartis for Common Cold Associated With Cough. The current trial status is completed. This product is registered under clinical trial identifier NCT02379637. Target conditions include Common Cold Associated With Cough.

What happened to similar drugs?

5 of 17 similar drugs in Common Cold Associated With Cough were approved

Approved (5) Terminated (3) Active (10)

✅Pseudoephedrine/ParacetamolJohnson & JohnsonApproved

✅Dextromethorphan + PlaceboNovartisApproved

✅VivaglobinCSLApproved

✅Acetylsalicylic acid (Aspirin, BAYE4465) + Paracetamol + PlaceboBayerApproved

✅Aspirin (Acetylsalicylic acid, BAYE4465) + PlaceboBayerApproved

🔄Lidocaine 8mg + CPC 2mg + Lidocaine 1mg + CPC 2mgNovartisPhase 3

🔄XylometazolineNovartisPhase 3

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT02379637	Phase 2	Completed	Jan 1, 2015	Apr 1, 2015	Common Cold Associated With Cough

Competing Products

20 competing products in Common Cold Associated With Cough

See all competitors

Product	Company	Stage	Hype Score
Nasal Glucagon + Oxymetazoline	Eli Lilly	Phase 1	29
New Formulation Phenylephrine HCl + Marketed Phenylephrine HCl + Placebo	Johnson & Johnson	Phase 2	27
Pseudoephedrine/Paracetamol	Johnson & Johnson	Approved	43
Zostavax®	Merck	Pre-clinical	18
Lidocaine 8mg + CPC 2mg + Lidocaine 1mg + CPC 2mg	Novartis	Phase 3	40
CDZ173	Novartis	Phase 2/3	38
Dextromethorphan + Placebo	Novartis	Approved	35
Xylometazoline	Novartis	Phase 3	40
Advil Congestion Relief + Advil Allergy and Congestion Relief + Paracetamol	Pfizer	Phase 3	32
pseudoephedrine hydrochloride 30 mg tablets + Placebo tablets	Pfizer	Phase 3	40
gammaglobulin	CSL	Pre-clinical	26
Human Normal Immunoglobulin for Subcutaneous Administration (IGSC)	CSL	Phase 3	40
Vivaglobin	CSL	Approved	43
Acetylsalicylic acid (Aspirin, BAYE4465) + Paracetamol + Placebo	Bayer	Approved	40
Aspirin (Acetylsalicylic acid, BAYE4465) + Placebo	Bayer	Approved	40
Acetylsalicylic acid (Aspirin, BAYE4465) & Lidocain + Acetylsalicylic Acid (Aspirin, BAYE4465) + Lidocain + Placebo	Bayer	Phase 3	37
Acetylsalicylic Acid (Aspirin Complex, BAYE4465) + Pseudoephedrine + Acetylsalicylic Acid (Aspirin, BAYE4465) + Pseudoephedrine + Placebo	Bayer	Phase 3	37
Acetylsalicylic Acid (Aspirin, BAYE4465) + Pseudoephedrine + Placebo	Bayer	Phase 3	37
Acetylcysteine + Paracetamol + Phenylephrine	Sandoz Group	Phase 3	29
A-101	Aclaris Therapeutics	Phase 3	30